Background
Human mesenchymal stem cells (hMSC) are a promising source for autologous cell therapies, particularly for orthopaedic tissue engineering [1] . MSC differentiation into osteoblasts results from an array of signalling cascades which are triggered by growth factors, physical and environmental stimuli which cross-talk with each other. These stimuli alter the expression of numerous regulatory factors including Wnt proteins. MSC have been shown to express a range of Wnt proteins and receptors and the pathway is a pivotal regulator of hMSC fate and osteoblast differentiation [2] , [3] .
Wnt signalling pathways have a multitude of effects on cell behaviour including changes to polarity and differentiation. The effects are dependent on cell type and Wnt protein context [4] , [5] . For example activation of canonical signalling has been shown to promote hMSC proliferation, preserve multipotency and inhibit differentiation [6] , [7] . However overexpression of the Wnt co-receptor LRP5 and active β-catenin has also been shown to promote osteogenic differentiation of hMSC [8] . Recently, we have demonstrated that immobilised Wnt molecules influence MSC migration and differentiation in 3D in vitro models [9] . In vivo, Wnt3A enhances skeletal progenitor cell proliferation, differentiation and accelerates bone repair in Axin2 knockout mice [10] .
Despite the significant role of Wnt in directing tissue formation, its use in vivo for bone repair has been limited. This is partly due to the complex and costly production methods required to produce pharmacological quantities of bioactive Wnt with the appropriate post-translational modifications [11] , [12] . Therefore, there is considerable interest in developing synthetic Wnt analogues to pharmacologically regulate Wnt signalling for therapeutic use. UM206 is a synthetic peptide based on a conserved fragment of Wnt3A and Wnt 5A. UM206 is a specific ligand for Frizzled1 and Frizzled2 receptors and is capable of activating canonical Wnt signalling depending on its conformation [13] .
The use of magnetic nanoparticles (MNP) to target cell signalling pathways is an expanding research area in biomedical research. Our previous work has demonstrated the efficacy of remotely activating Wnt signalling using oscillating magnetic fields with antibody-coated MNP targeted against Frizzled2 receptors [14] . The use of magnetite MNP for biomedical applications is particularly attractive due to the level of control that can be excised over particle shape, size, charge, coating, magnetization and dose [15] . MNP have been used for biomedical applications such as control of cell function and positioning in conjunction with magnetic fields. This can enable formation of heterotypic co-culture cell layers and complex tissue formation [16] , [17] . Incorporation of growth factor conjugated magnetite MNP into silk fibroin scaffolds has also shown efficacy in bone tissue engineering [18] . From a clinical perspective, the translational potential of magnetite based MNP is clear from their current use as MRI contrast agents [19] . A detailed review discussing the clinical applications of MNP in the context of orthopaedics is provided by Wimpenny et al [20] . We have demonstrated the potential applications of MNP in tissue engineering and regenerative medicine by targeting other mechanically responsive targets such as the TREK1 ion channel [21] , [22] , PDGF receptors [23] and Integrins [24] .
In this study, we report on the feasibility of using synthetic peptide-MNP conjugates for remote signalling mechano-activation. Initially, we have demonstrated the mechanism of Frizzled signal transduction and Wnt pathway activation via UM206-conjugated MNP and oscillating magnetic fields in hMSC using reporter systems. The potential use of UM206-conjugated MNP for directing bone formation remotely was then assessed using in vitro monolayer and 3D (ex vivo) foetal chick femur models [25] , [26] . The synergistic effects of MNP-mediated Wnt activation and BMP2 signalling on bone formation were also investigated. The overall aim of this research was to demonstrate that remote activation of Wnt signalling pathways in mesenchymal cell progenitors using peptide conjugated MNP can regulate remote controlled bone tissue formation. This technique has applications in both in vitro basic research and in orthopaedic cell therapies.
Methods
Cell culture. hMSC were isolated from fresh bone marrow (Lonza) as described in supplementary methods. Cells were expanded in basal media (10% FBS, 1% L-glutamine and 1% penicillin/streptomycin) (Lonza). Media was replaced twice per week and cells P1-5 were used in all experiments. Osteogenic media was prepared as described in supplementary methods. For Wnt-treated control groups diluted Wnt3A conditioned media collected from Wnt3A overexpressing L-M (TK-) cells (LGC standards) was used.
Transient transfections. hMSC were transiently transfected with a Gaussia Luciferase reporter under control of a TCF/LEF promoter as described previously [14] and in supplementary methods.
MNP coating. 250nm SPIO carboxyl functionalised MNP (Micromod) were covalently coated with UM206 peptide by carbodiimide activation as described previously [14] (Fig. 1a) and in supplementary methods. MNP coating was characterised as described in the supplementary methods.
Cell labelling with MNP. Cells were cultured in reduced serum basal media for 3h prior to addition of 25µg MNP/2x10 5 cells. Cells were incubated with MNP for 1.5h, then washed with PBS to remove unbound particles before addition of fresh media (Fig. 1b) .
Magnetic stimulation.
Magnetically stimulated groups were treated with ≥25mT magnetic fields using an oscillating magnetic force bioreactor (MICA Biosystems) as described previously [14] (Fig 1c) . Treatment was performed as described in supplementary methods.
Cell viability staining. Cells were labelled with MNP and treated with magnetic field stimulation as described above. After 14 days treatment, cells were washed with PBS then stained with a Live/dead assay as described in supplementary methods.
MTT assay. Cells were labelled with varying doses of L-/C-C-UM206-MNP or uncoated (blank) MNP (5μg to 300μg MNP/2x10 5 cells) or treated with varying doses of linear / cyclic UM206 peptide (1-100μg/mL). Magnetic field groups were treated with magnetic field stimulation as described above. After 14 days MTT assay was performed as described in supplementary methods.
Immunocytochemistry. MNP labelling of cells, β-catenin and Osteocalcin staining were assessed using immunofluorescence as described in supplementary methods.
Proximity ligation assay.
Frizzled receptor clustering was assessed using a proximity ligation assay (PLA) (Duolink, Sigma). Cells were seeded onto glass coverslips (1cm 2 ) and labelled with MNP as described above; magnetically stimulated groups were treated for 3h. Cells were fixed with 90% methanol and blocked as above and MNP and Frizzled2 were visualised by staining as described in supplementary methods.
Luciferase reporter assays. Experiments were performed in reduced serum basal media. At each time point, media samples were taken and analysed for luciferase activity using a luciferase flash assay kit (Thermo Pierce) on a Biotek Synergy 2 plate reader. Luciferase activity was normalised to the total protein content of cell lysates.
Chick femur culture and microinjection. Foetal chick femurs were extracted and treated as previously described [22] and in supplementary methods.
BMP2 microparticle encapsulation. BMP2 microparticles were prepared as previously described [22] and in supplementary methods.
X-ray microtomography. Chick femurs were analysed using X-ray microtomography (µCT) as previously described [22] and in supplementary methods. Immunohistochemistry. Femurs were processed as described in supplementary methods.
Statistical analysis.
All data is presented as means +/-SEM. Statistical significance at 95%
Confidence level was determined using 1-way ANOVA with post-hoc Tukey tests using
Mini-tab. μCT data was analysed by 1-way ANOVA with post-hoc Dunnett's test, all groups were compared to the Sham injection (control) group.
Results
The MNP coating efficiency was first determined using total protein assay and physical RT-PCR was then used to confirm Frizzled2 expression in hMSC. Frizzled2 was found to be stably expressed over 21 days in basal or osteogenic media ( Supplementary Fig. 1a ). Next, the effects of L-/ C-C UM206-MNP on Wnt signalling were assessed.
Immunocytochemistry was used to assess nuclear translocation of β-catenin. β-catenin mobilisation was enhanced in cells stimulated with Wnt3a-CM and L-UM206-MNP (and to a lesser extent with C-C-UM206-MNP), demonstrating that L-UM206-MNP are capable of stimulating β-catenin-mediated Wnt signal transduction (Fig 3A) . This effect was enhanced when cells were treated with L-UM206-MNP and magnetic field oscillation (Fig. 3B) . Next, the effects of L-/ C-C-UM206-MNP on the activity of a Wnt TCF/LEF luciferase reporter which was transiently transfected into hMSC was determined. Six hours after magnetic field stimulation (or treatment with Wnt3a-CM), reporter activity was increased in all groups except for magnetic field only control and cells cultured with Wnt3a-CM and DKK1, a negative regulator of Wnt pathway activation (Fig. 3C(i) ). DKK1 effectively inhibited
Wnt3A signal transduction, but had no effect on L-UM206-MNP mediated activation.
Furthermore, reporter activity was significantly higher when cells were treated with L-UM206-MNP compared to Wnt3a-CM. At 24h, reporter activity in the control groups remained at low levels, whilst Wnt3a-CM significantly increased reporter activity. Reporter activity of L-UM206-MNP stimulated cells persisted 24h after application of the magnetic stimulus and again was not affected by DKK1. In contrast to L-UM206-MNP, C-C-UM206-MNP had a negligible effect on Wnt-reporter activity compared to controls over both timepoints ( Fig. 3C(ii) ).
The mechanism of Wnt pathway activation by UM206-MNP was probed further using a proximity ligation assay to determine the degree of Frizzled receptor clustering in response to MNP. A basal level of receptor clustering was observed in non-treated cells. Treatment with Wnt3a-CM or magnetic field alone had no observable effect on receptor clustering (Fig 4a) .
In contrast, a noticeable increase in localised receptor clusters was observed in distinct cell populations when cells were treated with L-UM206-MNP, indicating that part of the receptor signal activation may be due to receptor clustering. A reduced level of receptor clustering was observed in response to C-C-UM206-MNP. In contrast control-MNP coated with nonspecific IgG had no effect on receptor clustering (supplementary fig. 3a ). Co-localisation analysis of MNP and Frizzled2 staining confirmed positive pixel overlap between MNP and Frizzled2 receptors in both L-UM206-MNP and C-C-UM206-MNP treated groups with or without magnetic field (Fig 4b) . The extent of MNP/receptor co-localisation was quantified (Fig. 6 A-C). Femurs were subjected to μCT analysis to assess changes in bone volume and density (Fig. 6A) . Injection of hMSC alone led to increases in relative bone collar volume but had no overall effect on bone collar density compared to Sham injected control. In contrast, injection of hMSC with BMP2-releasing microparticles, which provided an initial burst release of 60ng BMP2 followed by 10ng/day, resulted in an increase in diaphyseal bone collar density but had no overall effect on bone collar volume (Fig 6b) . Wnt pathway stimulation via L-UM206-MNP also resulted in an increase in relative bone collar density but had no overall effect on bone collar volume.
The largest effects on bone formation were observed when femurs were injected with L-UM206-MNP labelled MSC along with BMP2 releasing microparticles, which together caused an overall significant increase in relative bone collar density. Histological analysis of femurs confirmed the presence of secondary calcified mineralisation sites which were prevalent in the cell injected groups (with or without BMP2 and L-UM206-MNP) as shown by Alizarin red staining (Fig. 6C) , whilst negligible mineralisation was observed in the sham injected groups. Cell injected groups were also positive for Osteocalcin as shown by Immunohistochemistry (Fig. 6C) and evidence of tissue remodelling by increased collagen and/or sGAG deposition was observed in all cell and L-UM206-MNP / BMP2 injected groups as shown by Alcian blue and Sirius red staining (Fig. 6C ).
Discussion
In this study remote targeting and mechano-stimulation of Frizzled receptors for Wnt pathway activation using peptide-conjugated MNP has been demonstrated. It was also shown that this approach offers benefits in a bone tissue engineering context where the promotion of bone formation was achieved. In this investigation, UM206 peptides were coated onto magnetic nanoparticles and used to target MNP to Frizzled receptors at the cell membrane.
This allowed remote stimulation of Wnt signal transduction by applying an external magnetic field to oscillate the particle-receptor complex using forces in the piconewton (pN: 10−12N) range as previously calculated [27] . The efficiency of the MNP coating procedure was characterised by examining changes in the physical characteristics of coated MNP and by monitoring unbound protein content in the coating solution supernatants. MNP functionalisation with UM206 peptides resulted in a decrease in free protein and an increase in relative particle size and surface charge. This could be attributed to the peptide layer conjugated to the MNP surface and is consistent with previous work which also showed alterations in MNP properties after functionalisation [14] , [28] . Next we examined Frizzled2expression levels in MSC. MSC have previously been shown to express a number of Wnt ligands and receptors including Frizzled2 [2] . In this study, we also confirmed that MSC stably express Frizzled2 in basal or osteogenic media over three weeks. Our results also suggest that Frizzled2 expression is not regulated by short term stimulation with UM206-MNP or exogenous Wnt3a. This is also consistent with previous work which demonstrated that Frizzled2 expression is not regulated by Wnt3a in hMSC [29] . The potential cytotoxic effects of MNP are an important consideration when developing MNP based tissue engineering treatments. Our experiments show that UM206 peptide alone or MNP bound UM206 with or without magnetic field stimulation has no obvious cytotoxic effects on hMSC at a range of doses. This finding agrees with previous studies which have shown the biocompatibility of iron-oxide based MNP in numerous cell types [30] , [31] , [32] , [33] , [34] .
Downstream indicators of Wnt pathway activation by UM206-MNP were investigated by assessing β-catenin localisation and end-point activation of TCF/LEF responsive signalling.
Our results demonstrate that L-UM206-MNP (and to a lesser extent C-C-UM206-MNP) were capable of initiating nuclear translocation of β-catenin to a similar level as Wnt3a, this is comparable to other studies where Wnt has been shown to initiate β-catenin translocalisation [35] . In addition, our results demonstrate that L-UM206-MNP elevate downstream TCF/LEF expression after 6h which can be maintained up to 24h after treatment. In contrast, Wnt3a marginally elevated pathway activity after 6h but peak activity was observed after 24h, which suggests that L-UM206-MNP mediated activation may initiate a more rapid downstream activation. Interestingly, in contrast with L-UM206-MNP, particles coated with C-C-UM206
peptide had a negligible effect on Wnt reporter activity and only marginally increased β-catenin mobilisation. This may be a result of the lower binding affinity of the cyclic peptide compared to the linear peptide [13] . It is also possible that conjugation of multiple cyclic UM206 ligands to MNP may be inducing steric hindrance which may disrupt receptor binding affinity and reduce the signalling activity of the cyclic peptide.
Our results demonstrated that pathway activation by L-UM206-MNP is not affected by DKK1, an inhibitor of the LRP co-receptor involved in canonical pathway activation, whereas Wnt3a mediated activation was successfully blocked with DKK1. This indicates that LRP is not involved in L-UM206-MNP mediated activation and suggests that MNP stimulate Wnt signalling by an alternative mechanism. This observation is in agreement with our previous work which has shown that antibody-MNP mediated Wnt pathway activation is also independent of LRP receptors [14] . We also employed a PLA assay to assess Further work is required to elucidate the phenotype of these cells. Receptor clustering is a common mechanism of cell signalling activation and has previously been demonstrated using alternate magnetic particle activation systems [37] . Wnt pathway activation by receptor clustering has also been demonstrated in Xenopus embryos where Frizzled3 was found to form active dimers [38] . In contrast to UM206-MNP, no changes in receptor clustering were observed in Wnt3a treated cells. This can be expected as conventional signal activation by Wnt occurs through a complex of Wnt, Frizzled and LRP co-receptors and not necessarily through Frizzled dimers [39] . The mechano-responsiveness and activation of the Wnt pathway has been explored using other approaches. Fluid shear stress or mechanical strain using 4-point bending systems have been shown to initiate β-catenin translocation and activate TCF reporter systems [40] , [41] . It is therefore possible that mechano-stimulation of Frizzled receptors using MNP is enough to induce a signalling response. Taken together, our results suggest a contrasting activation mechanism between MNP and native Wnt ligands.
Our results confirm that Wnt pathway activation plays a role in hMSC osteogenesis. Wnt has been shown to have both inhibitory and promoting effects on MSC osteogenesis [5] . Our recent work utilising immobilised Wnt3a/collagen gel platforms has demonstrated the directional and inductive cues of a Wnt bound platform where MSCs located proximal to the Wnt signal maintain stem cell marker expression whilst migrated cells located distally to the Wnt signal display an osteogenic phenotype [9] . These results also agree with previous work, for example Wnt3a or GSK-3β inhibitors have been shown to promote MSC proliferation and maintain multipotency or promote MSC osteogenesis under certain doses and cellular contexts [6] , [7] , [42] , [43] . In our studies intermittent stimulation of hMSC with L-UM206-MNP over 28 days resulted in localised collagen synthesis, matrix maturation and mineralisation indicating a differentiated osteoblast phenotype. In contrast, treatment with Wnt3a for 28 days resulted in decreased mineralised matrix formation. This discrepancy could be explained by the contrasting dose-response effects of Wnt activation through MNP vs native Wnt. Our data suggest that Wnt pathway activation through L-UM206-MNP is a transient stimulus which is initially beneficial for hMSC lineage commitment to osteogenesis but enables terminal osteoblast differentiation after signal dissipation. Interestingly, this observation mirrors the effects of immobilised Wnt3a on MSC proliferation/differentiation seen by Lowndes et al [9] and also agrees with the findings of Ling et al [42] and Janeczek et al [44] who also showed that a transient Wnt signal is beneficial for hMSC commitment to the osteogenic lineage but withdrawal of Wnt is required for terminal osteoblast differentiation.
The interactions between Wnt and other signalling pathways are complex [45] . Here we investigated the effects of combining Wnt stimulation via L-UM206-MNP with BMP2
release from polymer microspheres which have applications in bone tissue engineering [46] .
In these experiments we used the foetal chick femur, an established model of endochondral bone development [47] , [48] . In this model, bone formation at the bone collar was increased by hMSC injection alone, whilst injection of BMP2 with hMSC or L-UM206-MNP labelled hMSC resulted in increases in bone density, indicating a more mature, functional matrix. The biggest increases in bone density were seen when L-UM206-MNP labelled MSC were coadministered with BMP2 microspheres. During bone formation, Wnt and BMP2 have been shown to act reciprocally to regulate osteoblast differentiation [49] . Our previous work has also demonstrated the anabolic effects of BMP2 releasing microspheres [22] . The link between BMP2 and Wnt signalling has also been demonstrated by Vaes et al [50] Scale bar represents 50µm. End point Wnt signalling was assessed using a TCF/LEF luciferase reporter 6h and 24h after treatment (C). Wnt3a-CM increased reporter activity after 6h and 24h (significant), and was blocked by Dickkopf-related protein 1 (DKK1). L-UM206-MNP significantly increased Wnt reporter activity at both time-points and was not affected by DKK1. L-UM206-induced reporter activity was also significantly higher than in Wnt3a-CM groups at 6h (C(i)). This dataset is part of a larger dataset part of which has been published previously [14] . Treatment with C-C-UM206 MNP (C(ii)) had no overall effect on TCF/LEF reporter activity. Error bars represent SEM, n=4. * denotes p<0.05, # denotes p>0.05. 
